1. Home
  2. ZVRA vs AAM Comparison

ZVRA vs AAM Comparison

Compare ZVRA & AAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • AAM
  • Stock Information
  • Founded
  • ZVRA 2006
  • AAM 2024
  • Country
  • ZVRA United States
  • AAM United States
  • Employees
  • ZVRA N/A
  • AAM N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • AAM
  • Sector
  • ZVRA Health Care
  • AAM
  • Exchange
  • ZVRA Nasdaq
  • AAM Nasdaq
  • Market Cap
  • ZVRA 467.6M
  • AAM 460.0M
  • IPO Year
  • ZVRA 2015
  • AAM 2024
  • Fundamental
  • Price
  • ZVRA $10.18
  • AAM $10.55
  • Analyst Decision
  • ZVRA Strong Buy
  • AAM
  • Analyst Count
  • ZVRA 7
  • AAM 0
  • Target Price
  • ZVRA $22.57
  • AAM N/A
  • AVG Volume (30 Days)
  • ZVRA 1.8M
  • AAM 1.6K
  • Earning Date
  • ZVRA 11-05-2025
  • AAM 01-01-0001
  • Dividend Yield
  • ZVRA N/A
  • AAM N/A
  • EPS Growth
  • ZVRA N/A
  • AAM N/A
  • EPS
  • ZVRA N/A
  • AAM 0.32
  • Revenue
  • ZVRA $62,020,000.00
  • AAM N/A
  • Revenue This Year
  • ZVRA $336.43
  • AAM N/A
  • Revenue Next Year
  • ZVRA $54.26
  • AAM N/A
  • P/E Ratio
  • ZVRA N/A
  • AAM $32.91
  • Revenue Growth
  • ZVRA 161.81
  • AAM N/A
  • 52 Week Low
  • ZVRA $6.19
  • AAM $10.03
  • 52 Week High
  • ZVRA $13.16
  • AAM $10.79
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 47.76
  • AAM 64.44
  • Support Level
  • ZVRA $10.03
  • AAM $10.56
  • Resistance Level
  • ZVRA $11.23
  • AAM $10.60
  • Average True Range (ATR)
  • ZVRA 0.56
  • AAM 0.02
  • MACD
  • ZVRA -0.14
  • AAM 0.00
  • Stochastic Oscillator
  • ZVRA 7.41
  • AAM 100.00

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About AAM AA Mission Acquisition Corp. Class A Ordinary Shares

AA Mission Acquisition Corp is a blank check company.

Share on Social Networks: